Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report

By                      

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1633-1636

Spandidos Publications

Access to resources Recommend Favorite

NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis

By Liu Li-Li   Zhang Mei-Fang   Pan Ying-Hua   Yun Jing-Ping   Zhang Chris  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1763-1774

Springer Publishing Company

Access to resources Recommend Favorite

Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient

By Medioni Jacques   Cojocarasu Oana   Banu Eugeniu   Cassar-Queudeville Alexia   Halimi Philippe   Oudard Stéphane  

Targeted Oncology, Vol. 2, Iss. 3, 2007-07 ,pp. : 193-195

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma

By                          

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 101-108

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling

By              

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 177-188

Spandidos Publications

Access to resources Recommend Favorite